[Studies on quinolone antibiotics. III. Synthesis and antibacterial activity of 5-amino-7-(2-aminoalkoxy)-1-cyclopropyl-6-fluoro-1,4- dihydro-4-oxoquinoline-3-carboxylic acid and their derivatives]. 1991

T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
Central Research Laboratories, Hokuriku Seiyaku Co. Ltd., Fukui, Japan.

5-Amino-7-(2-aminoalkoxy)-1-cyclopropyl-6-fluoro-1,4-dihydro-4- oxoquinoline-3-carboxylic acid and their derivatives (10, 11) were prepared and their antibacterial activities were evaluated. As a result of in vitro antibacterial screening, the compounds having mono- or di-methyl (11d, e) group at alpha-position of amino group were most effective among the 7-aminoalkoxy derivatives. Structure-activity relationship of these compounds is also discussed.

UI MeSH Term Description Entries
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone

Related Publications

T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
May 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
March 2008, Bioorganic & medicinal chemistry,
T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
January 1993, Chemical & pharmaceutical bulletin,
T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
January 2014, European journal of medicinal chemistry,
T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
October 1986, Journal of medicinal chemistry,
T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
January 2016, Bioorganic & medicinal chemistry letters,
T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
September 1990, Chemical & pharmaceutical bulletin,
T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
January 1993, Yao xue xue bao = Acta pharmaceutica Sinica,
T Yoshida, and Y Yamamoto, and N Yagi, and Y Takahasi, and S Yasuda, and H Katoh, and Y Itoh
January 1986, Proceedings of the Western Pharmacology Society,
Copied contents to your clipboard!